Hepatolithiasis associated with cholangiocellular carcinoma is occasionally a calcium bilirubinate stone. Primary cholesterol hepatolithiasis associated with cholangiocellular carcinoma is rare; only 6 cases have been reported in the literature. A 55-year-old man was admitted to our hospital because of an elevated level of carbohydrate antigen 19-9.
Introduction
Primary hepatolithiasis is well known as an endemic disease prevalent in Southeast Asia, including Japan, Korea, China, and Taiwan; it is very rare among Caucasians (1, 2) .
The nature of primary hepatolithiasis is mostly calcium bilirubinate, and some of the stones are cholesterol-rich pigment stones (3) . Primary cholesterol hepatolithiasis is extremely rare (4) . Particular cases of primary cholesterol hepatolithiasis of more than 90% cholesterol composition have been reported in Japan (5,6). Hepatolithiasis is occasionally associated with cholangiocellular carcinoma (CCC) (7, 8) and the stones of primary hepatolithiasis associated with CCC are calcium bilirubinate stones in almost all reported cases (7, 8) . Primary cholesterol hepatolithiasis associated with CCC is rare.
Herein, we present such a rare case.
Case report
In October 2004, a 55-year-old male was hospitalized because of an elevated level of carbohydrate antigen 19-9 (CA19-9). He had been admitted to our hospital because of liver dysfunction, although he was asymptomatic; he was referred to our department for further examination at age 52. Laboratory data showed that the CA19-9 was 15.3 U/mL (normal range: <37 U/mL). He had been diagnosed as having primary cholesterol hepatolithiasis, on the basis of ultrasonography (US), computed tomography (CT) and endoscopic retrograde cholangiogram (ERC) findings. US demonstrated focally dilated ducts containing highly echogenic material with strong shadowing in the peripheral segments of the liver. However, no wall thickness, stones or debris was seen in the gallbladder. CT revealed only subtle dilatation of peripheral bile duct. ERC revealed the dilated common bile duct (15 mm in diameter) with filling defects (up to 12 mm in diameter), and intrahepatic cylindrical duct dilatation with internal filling defects in the right anterior subsegmental branch duct of segment VIII of the liver. There was no stricture of the bile duct. He underwent endoscopic sphincterotomy for round whitish-yellow cholesterol stones. These stones contained 95% cholesterol in dry weight, by chemical analysis. A bacteriological study of the intrahepatic bile was negative. He was monitored with laboratory data and US, CT at regular intervals. We continued careful observation as intrahepatic stones remained, and stone fall into the common bile duct was considered likely. In May 2004, follow-up CT scan revealed a low-density area close to the right adrenal gland in segment VII of the liver (Fig. 1A) , US did not reveal the tumor at this stage, and the abnormal finding was diagnosed as inflammatory granular changes. Laboratory data showed that the CA19-9 was 50.4 U/mL, and in July the value was increased to 66.5 U/mL. In September 2004, CT scan detected a mass close to the right adrenal gland and diaphragm in segment VII of the liver (Fig. 1B) . The mass was associated with the elevation of the CA19-9. He had family history of bile duct stone apparent in his parent and three siblings (Fig. 2) . On admission to our hospital, his abdomen was soft; no mass was palpable. Results of laboratory tests were as follows: total bilirubin, 1. Histopathological examination revealed moderately to poorly differentiated adenocarcinoma ( Fig. 4B) with infiltration into the right adrenal glands (Fig. 4C ).
Vascular and perineural invasion was noted. A crystalloid pattern was observed in the structure of the stones, showing the characteristics of cholesterol stone (Fig. 4D) . The inflammatory and fibrotic changes around the bile duct wall were scanty (Fig. 4D) . A few tiny cholesterol stones were scattered in the peripheral intrahepatic bile ducts, at different locations. The postoperative course was uneventful. The level of CA19-9 gradually lowered to the normal range. However, his serum CA19-9 level was elevated to 56.8 U/mL in July 2005. He relapsed into disease 10 months after the surgical operation, and was diagnosed as having peritoneal carcinomatosis at laparotomy for observation. The patient has been surviving for 25 months after the surgical operation, treated with systemic combination chemotherapy (gemcitabine and cisplatin). His serum CA19-9 level has gradually lowered to 41.9 U/mL, although it has not reached the normal range.
Discussion
We herein described a case of primary cholesterol hepatolithiasis associated with In conclusion, we reported a rare case of primary cholesterol hepatolithiasis associated with peripheral cholangiocellular carcinoma. 
